Proposed Rule 27 Mar 2025 compliance, regulations, aviation, faa, safety, aircraft, aviation safety, incorporation by reference, air transportation, airbus, airworthiness

✈️Proposed Airworthiness Directive on Airbus SAS

The FAA proposes to supersede Airworthiness Directive (AD) 2016-14-03, which applies to all Airbus SAS Model A319-111, -112, -113, -114, -115, -131, -132, and -133 airplanes; Model A320-211, -212, -214, -231, -232, and -233 airplanes; and Model A321-111, -112, -131, -211, - 212, -213, -231, and -232 airplanes. AD 2016-14-03 requires reinforcing the forward pressure bulkhead at a certain stringer on both the left- hand and right-hand sides and doing related investigative and corrective actions if necessary. Since the FAA issued AD 2016-14-03, new crack findings have prompted the need for repetitive inspections of the area. This proposed AD would continue to require the actions in AD 2016-14-03, add repetitive inspections of structure at a certain frame and applicable corrective actions, provide a terminating action for the repetitive inspections, and remove airplanes from the applicability, as specified in a European Union Aviation Safety Agency (EASA) AD, which is proposed for incorporation by reference (IBR). The FAA is proposing this AD to address the unsafe condition on these products.

Learn More
Notice 27 Mar 2025 compliance, environmental regulations, fisheries, noaa, business meeting, caribbean

🎣Caribbean Fishery Management Council Public Meeting Notice

The Caribbean Fishery Management Council (CFMC) will hold the 186th public hybrid meeting to address the items contained in the tentative agenda included in the SUPPLEMENTARY INFORMATION.

Learn More
Notice 27 Mar 2025 compliance, regulation, manufacturing, pharmaceutical, dea, controlled substances, cannabis, bulk manufacturing

🌿DEA Notice for Bulk Manufacturer of Marihuana

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.

Learn More
Notice 27 Mar 2025 compliance, banking, federal reserve, state member banks, security program

🏦Federal Reserve Proposed Information Collection on Bank Security

The Board of Governors of the Federal Reserve System (Board) invites comment on a proposal to extend for three years, without revision, the Written Security Program for State Member Banks (FR 4004; OMB No. 7100-0112).

Learn More
Notice 27 Mar 2025 compliance, federal reserve, reporting requirements, financial data, banking regulation

🏦Federal Reserve Announces Revision for Financial Reporting Requirements

The Board of Governors of the Federal Reserve System (Board) is adopting a proposal to extend for three years, with revision, the Report of Selected Assets and Liabilities of Domestically Chartered Commercial Banks and U.S. Branches and Agencies of Foreign Banks (FR 2644; OMB No. 7100-0075).

Learn More
Notice 27 Mar 2025 compliance, trading, securities, cboe, financial regulation, liquidity, stock exchange

⏰Cboe BZX Extends Early Trading Session Hours to Enhance Liquidity

The Cboe BZX Exchange has proposed a rule change to extend its Early Trading Session hours from 7

Learn More
Rule 27 Mar 2025 compliance, regulation, consumer protection, safety, imports, incorporation by reference, law enforcement, cpsc, labeling, consumer safety, infants and children, stationary activity centers, toys, astm f2012-24

🚼New Safety Standard for Stationary Activity Centers Effective July 2025

In June 2019, the U.S. Consumer Product Safety Commission (CPSC or Commission) published a consumer product safety standard for stationary activity centers pursuant to section 104 of the Consumer Product Safety Improvement Act of 2008 (CPSIA). The Commission's mandatory standard incorporates by reference ASTM F2012-18[egr]\1\, Standard Consumer Safety Performance Specification for Stationary Activity Centers. The CPSIA sets forth a process for updating mandatory standards for durable infant or toddler products that are based on a voluntary standard, when a voluntary standards organization revises the standard. In November 2024, ASTM published a revised voluntary standard. This direct final rule updates the mandatory standard for stationary activity centers to incorporate by reference the 2024 version of ASTM F2012, which the Commission has allowed to become the mandatory standard under section 104. The purpose of the direct final rule is to conform the Code of Federal Regulations (CFR) to the correct version of ASTM F2012 to provide an accurate reference to the standard that will be enforced as a mandatory rule.

Learn More
Notice 27 Mar 2025 compliance, healthcare, regulation, pharmaceuticals, georgia, dea

🚫Revocation of DEA Registration for Physician in Georgia

The Drug Enforcement Administration has revoked Dr. Harvey Leslie's DEA registration due to his inability to prescribe controlled substances after the revocation of his Georgia medical license. The document outlines the regulatory process leading to this decision and the implications of default by the registrant.

Learn More
Notice 27 Mar 2025 compliance, pharmaceuticals, regulatory notice, controlled substances, drug enforcement, import application

⚖️Restek Corporation's Import Application for Controlled Substances Notice

Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 27 Mar 2025 compliance, regulations, transportation, motor carriers, safety, driver health

🚚FMCSA Renewed Exemptions for Drivers with Epilepsy and Seizures

FMCSA announces its decision to renew exemptions for 19 individuals from the requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) that interstate commercial motor vehicle (CMV) drivers have "no established medical history or clinical diagnosis of epilepsy or any other condition which is likely to cause loss of consciousness or any loss of ability to control a CMV." The exemptions enable these individuals who have had one or more seizures and are taking anti-seizure medication to continue to operate CMVs in interstate commerce.

Learn More